NasdaqEvotec Adds Licence From ERS Genomics To CRISPR Service …NasdaqEvotec AG announced Wednesday that it has expanded its CRISPR service offering with the addition of a licence of CRISPR-Cas9 technology from ERS.Evotec Expands CRISPR-Based Technolo… Continue reading
Worldwide Hemophilia Gene Therapy Market by 2023 Opportunities, Strategies, Challenges, Supply, Demand, Market …Pharmaceuticals NewsHemophilia Gene Therapy Market Report offers a comprehensive study including companies products, applications and Fore… Continue reading
Business Wire (press release)ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to EvotecBusiness Wire (press release)“This license enables them to further expand their service offering in the CRISPR gene-editing space.” Evotec uses the CRISPR/Ca… Continue reading
IU NewsroomVascugen licenses stem cell tech for blood vessel regeneration developed at IU School of MedicineIU NewsroomThe company holds the rights to an exclusive, worldwide license to a broad patent portfolio encompassing the repair, regeneration and… Continue reading
|
Bismarck clinic agrees to repay patients $20K, discontinue stem cell injections
Bismarck Tribune Following an investigation by the North Dakota Attorney General’s office, a Bismarck stem cell clinic has agreed to pay nearly $20,000 in consumer refunds and discontinue stem cell injections not approved by the U.S. Food and Drug Administration. An … |